Beta-Klotho Protein Expression in Healthy Human Tissues and Liver Biopsies From Patients With MASLD or MASH

Background and Aims: Biologics based on the structure of fibroblast growth factor (FGF) 19 and 21 show strong beneficial effects in the treatment of metabolic dysfunction–associated steatotic liver disease (MASLD), including compensated cirrhosis. Studies in rodents indicated that the effectiveness...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Alexandra S. Aaldijk, Dicky Struik, Stan Driessen, Cristy R.C. Verzijl, Joanne Verheij, Max Nieuwdorp, Roos Eilers, Justina C. Wolters, Adriaan G. Holleboom, Johan W. Jonker
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier 2025-01-01
Serier:	Gastro Hep Advances
Fag:	FGF19 FGF21 MASLD Hepatic Steatosis Inflammation
Online adgang:	http://www.sciencedirect.com/science/article/pii/S2772572325001323
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!